VARIPED · MSD · 1 Dose Vial + Diluent · Subcutaneous Injection
Pack Details · Store at 2–8°C · Protect from Light
Chickenpox spreads rapidly among children and can cause complications like skin infections and pneumonia. IAP recommends 2 doses — first around 15 months, second at 4–6 years.
Anyone above 13 years with no history of chickenpox or prior vaccination should receive 2 doses, 4–8 weeks apart. Adults tend to have more severe disease than children.
Chickenpox during pregnancy can harm the baby. Susceptible women should complete vaccination at least 1 month before conception. Not to be given during pregnancy itself.
Staff without prior immunity working around patients, newborns or immunocompromised individuals should be vaccinated to prevent transmission.
A single dose given within 72–120 hours of exposure to a chickenpox case can prevent or significantly reduce disease severity in susceptible contacts.
Each single-dose vial, after reconstitution with the supplied 0.5 mL diluent, typically contains:
| Component | Quantity | Notes |
|---|---|---|
| ACTIVE INGREDIENT | ||
| Live Attenuated Varicella-Zoster Virus (Oka/Merck Strain) | Not less than 1000 PFU | Freeze-dried powder, reconstituted before injection |
| EXCIPIENTS / STABILISERS | ||
| Sucrose, Hydrolyzed Gelatin & Amino Acids | Stabiliser | Standard stabiliser system for the Oka/Merck strain formulation |
| Neomycin (trace residual) | Trace | From cell-culture manufacturing process |
| Sterile Water for Injection | 0.5 mL | Diluent supplied in a prefilled syringe |
| Age Group | Number of Doses | Timing | Notes |
|---|---|---|---|
| Children 9–12 months to 12 years | 2 Doses | 1st dose ~15 months; 2nd dose at 4–6 years | Minimum gap of 3 months between doses if under 13 years |
| Adolescents & Adults (13 years+) | 2 Doses | 4–8 weeks apart | Required for anyone without confirmed immunity |
| Post-Exposure Prophylaxis | 1 Dose | Within 72–120 hours of exposure | May prevent or reduce severity of disease |
| Women Planning Pregnancy | 2 Doses | Complete course ≥1 month before conception | Contraindicated during pregnancy itself |
VARIPED has a well-established safety profile similar to other Oka-strain varicella vaccines. Most reactions are mild and resolve within a few days.
| Feature | VARIPED (MSD) | Varilrix (GSK) | NEXIPOX PLUS (Novo Scier) |
|---|---|---|---|
| Virus Strain | ✓ Live Attenuated Oka/Merck Strain | Live Attenuated Oka Strain | Live Attenuated Oka Strain |
| Stabiliser Technology | Sucrose & Hydrolyzed Gelatin | Manufacturer-specific stabiliser | 2X Trehalose Protection (Gelatin-Free) |
| Diluent Presentation | Supplied Diluent | Ampoule/vial diluent | Prefilled Syringe Diluent |
| Free Injection Accessories | As per pack | As per pack | Free BD Syringe + 2 Needles |
| Dose Schedule | 2 Doses | 2 Doses | 2 Doses |
| Route of Administration | Subcutaneous | Subcutaneous | Subcutaneous |
| Cold Chain Storage | 2–8°C | 2–8°C | 2–8°C |
All DCGI-approved varicella vaccines available in India use the same live attenuated Oka strain and offer comparable protection. VARIPED uses MSD's well-established Oka/Merck strain with a long global safety record. Call us to discuss the best option for your family.
Trained, certified nurses experienced in administering live vaccines correctly via the subcutaneous route, for all age groups from infants to adults.
VARIPED transported in validated cold boxes at 2–8°C from procurement to injection. Never frozen. Full cold chain compliance on every home visit.
Sourced exclusively from authorised distributors. Batch number and expiry date shared on your WhatsApp receipt after vaccination.
We track your first and second dose schedule and send timely reminders so your complete 2-dose course is finished on time.
Copyright © All Rights Reserved VacciHub by PSTRIDE SOLUTIONS LLP
